1-17 of 17
Ephraim Hochberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multicenter Phase II Trial of Zanubrutinib, Obinutuzumab, and Venetoclax (BOVen) in Treatment-Naïve Chronic Lymphocytic Leukemia: 5-Year Follow up, Retreatment Outcomes, and Impact of MRD Kinetics (ΔMRD400)

Free
Jacob D. Soumerai, Ahmet Dogan, Venkatraman Seshan, Kelsey Leigh Flaherty, Natalie Slupe, Jason Carter, Ephraim Hochberg, Jeffrey A. Barnes, Jeremy S. Abramson, Audrey Hamilton, Ariela Noy, Colette Owens, Maria Lia Palomba, Anita Kumar, Lindsey Roeker, Meghan C. Thompson, Ronald W. Takvorian, Zachary D. Epstein-Peterson, Mark Blaine Geyer, Gilles Salles, Robert Stuver, Philip Caron, Prioty Islam, Tamanna Haque, Paola Ghione, Raphael E. Steiner, Pallawi Torka, Kevin A. David, Jennifer Kimberly Lue, Paul A. Hamlin, Alison Moskowitz, Lorenzo Falchi, Julie Haydu, Patrick Connor Johnson, Joanna Mi, Jessica Pendleton, Alyssa Labarre, Rosalba Martignetti, Sean F. Plummer, Maria Chabowska, Walter Ramos Amador, Neena Mahajan, Morgan Choma, Clare Grieve, Rayna N. Garcia, Hailey E. Kelly, Ella Mallinger, James O'Grady, Bernadette Beatty, Michelle Adams, Athina Apazidis, Aileen Cleary Cohen, Mina Shahkarami, Allison P. Jacob, Omar Abdel-Wahab, Andrew D. Zelenetz
Journal: Blood
Blood (2024) 144 (Supplement 1): 1867.
https://doi.org/10.1182/blood-2024-205697
Published: 2024
Journal Articles

Molecular Residual Disease Detection Via Cancer Personalized Profiling By Deep Sequencing in Patients with PTCL Undergoing Autologous Stem Cell Transplantation

Free
Chandan Sanghera, Josie Ford, Ruwan Gunaratne, Kusha Chopra, Anna B Rider, Aliyah R. Sohani, Sean M McCabe, Ronald A Nemec, Yi-Bin Chen, Steven McAfee, Ephraim Hochberg, Jeffrey A. Barnes, Caroline MacVicar, Eric D. Jacobsen, Mwanasha H. Merrill, Michael S. Khodadoust, David Kurtz, Salvia Jain
Journal: Blood
Blood (2024) 144 (Supplement 1): 6202.
https://doi.org/10.1182/blood-2024-206116
Published: 2024
Journal Articles

Safety and Efficacy of Ibrutinib Maintenance (I-M) Following Frontline Induction in Mantle Cell Lymphoma (MCL) with Sequential Assessment of Changes in NGS-MRD

Free
Reem Karmali, Jeremy S. Abramson, Deborah M. Stephens, Jeffrey A Barnes, Jason Kaplan, Jane N. Winter, Shuo Ma, Juehua Gao, Adam M Petrich, Ephraim Hochberg, Tak Takvorian, Frank Kuhr, Lik Wee Lee, Valerie Nelson, Leo I. Gordon, Barbara Pro
Journal: Blood
Blood (2021) 138 (Supplement 1): 3530.
https://doi.org/10.1182/blood-2021-144707
Published: 2021
Journal Articles

Longer Term Follow-up of a Multicenter, Phase 2 Study of Ibrutinib Plus Fludarabine, Cyclophosphamide, Rituximab (iFCR) As Initial Therapy for Younger Patients with Chronic Lymphocytic Leukemia

Free
Matthew S. Davids, Danielle M. Brander, Svitlana Tyekucheva, Chinheng Chen, James Kaminski, Josie Montegaard, Alvaro J. Alencar, Leyla Shune, Mohammad Omaira, Caron Jacobson, Philippe Armand, Samuel Y. Ng, Jennifer L. Crombie, Ann S. LaCasce, Jon E. Arnason, Ephraim Hochberg, Ronald W. Takvorian, Jeremy S. Abramson, David C. Fisher, Jennifer R Brown
Journal: Blood
Blood (2021) 138 (Supplement 1): 640.
https://doi.org/10.1182/blood-2021-146624
Published: 2021
Journal Articles

Ibrutinib Maintenance (I-M) Following Intensive Induction in Mantle Cell Lymphoma (MCL): Efficacy, Safety and Changes in Minimal Residual Disease

Free
Reem Karmali, MDMSc, Jeremy S Abramson, MD MMSc, Deborah M. Stephens, DO, Jeffrey A Barnes, MD PhD, Jason Kaplan, MD, Jane N. Winter, MD, Shuo Ma, MD PhD, Juehua Gao, MD PhD, Adam M Petrich, MD, Ephraim Hochberg, MD, Ronald Takvorian, Frank Kuhr, PhD, Valerie Nelson, MD MBA, Leo I. Gordon, MD, Barbara Pro, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-137695
Published: 2020
Journal Articles

Ibrutinib Maintenance (I-M) Following Frontline Intensive Induction in Mantle Cell Lymphoma (MCL): Interim Safety, Response and Sequential MRD Evaluation

Free
Reem Karmali, MD, Jeremy S. Abramson, MD MMSc, Deborah M. Stephens, DO, Jeffrey A. Barnes, MD PhD, Jason Kaplan, MD, Jane N. Winter, MD, Shuo Ma, MD PhD, Juehua Gao, MD PhD, Adam M. Petrich, MD, Ephraim Hochberg, MD, Ronald W. Takvorian, MD, Frank Kuhr, PhD, Valerie Nelson, MD MBA, Leo I. Gordon, MD, Barbara Pro, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3990.
https://doi.org/10.1182/blood-2019-126920
Published: 2019
Journal Articles

Initial Results of a Multicenter, Phase II Study of Ibrutinib Plus FCR (iFCR) As Frontline Therapy for Younger CLL Patients

Free
Matthew S. Davids, Haesook T. Kim, PhD, Danielle M. Brander, MD, Jad Bsat, BA, Alexandra Savell, BS, Karen Francoeur, RN, Jeffrey Hellman, PA-C, Caron A. Jacobson, MD, Ephraim Hochberg, MD, Ronald Takvorian, MD, Jeremy S. Abramson, MD, David C. Fisher, MD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3243.
https://doi.org/10.1182/blood.V128.22.3243.3243
Published: 2016
Journal Articles

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma

Free
Brief Report
Oreofe Odejide, Oliver Weigert, Andrew A. Lane, Dan Toscano, Matthew A. Lunning, Nadja Kopp, Sunhee Kim, Diederik van Bodegom, Sudha Bolla, Jonathan H. Schatz, Julie Teruya-Feldstein, Ephraim Hochberg, Abner Louissaint, David Dorfman, Kristen Stevenson, Scott J. Rodig, Pier Paolo Piccaluga, Eric Jacobsen, Stefano A. Pileri, Nancy L. Harris, Simone Ferrero, Giorgio Inghirami, Steven M. Horwitz, David M. Weinstock
Journal: Blood
Blood (2014) 123 (9): 1293–1296.
https://doi.org/10.1182/blood-2013-10-531509
Published: 2014
Includes: Supplemental data
Journal Articles

Final Results Of a Phase I Study Of The Anti-CD22 Antibody-Drug Conjugate (ADC) DCDT2980S With Or Without Rituximab (RTX) In Patients (Pts) With Relapsed Or Refractory (R/R) B-Cell Non-Hodgkin’s Lymphoma (NHL)

Free
Ranjana Advani, MD, Andy I. Chen, MD, PhD, Daniel Lebovic, MD, Mark W. Brunvand, MD, Andre Goy, MD, Julie E. Chang, MD, Ephraim Hochberg, Sreeni Yalamanchili, BSPharm, Robert Kahn, Dan Lu, Akiko Chai, MS, Yu-Waye Chu, Bruce D. Cheson, M.D.
Journal: Blood
Blood (2013) 122 (21): 4399.
https://doi.org/10.1182/blood.V122.21.4399.4399
Published: 2013
Journal Articles

Response to Dasatinib In Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Correlates with p-Lyn and p-Syk

Free
Philip C. Amrein, MD, Eyal C Attar, MD, Tak Takvorian, M.D., Ephraim Hochberg, Karen K Ballen, MD, Kathleen M Leahy, David C. Fisher, MD, Ann LaCasce, MD, MSc, Eric D Jacobsen, MD, Philippe Armand, MD, PhD, Robert Hasserjian, MD, Lillian Werner, Donna Neuberg, ScD, Jennifer R Brown, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2457.
https://doi.org/10.1182/blood.V116.21.2457.2457
Published: 2010
Journal Articles

Statin Use Improves Overall Survival and Time to Treatment Failure in Patients with Primary CNS Lymphoma.

Free
Lauren Ciminello, Christiana Toomey, Julien Cobert, Fred H Hochberg, MD, Jeremy S. Abramson, MD, Ephraim Hochberg, MD
Journal: Blood
Blood (2009) 114 (22): 2496.
https://doi.org/10.1182/blood.V114.22.2496.2496
Published: 2009
Journal Articles

Automated Analysis and Codification of Free Text Pathology Reports

Free
Bill Long, Aliyah Rahemtullah, MD, Christiana E. Toomey, Adam Ackerman, Jeremy S. Abramson, MD, Ephraim Hochberg, MD
Journal: Blood
Blood (2008) 112 (11): 2394.
https://doi.org/10.1182/blood.V112.11.2394.2394
Published: 2008
Journal Articles

Dasatinib Has Activity in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL/SLL), a Phase II Trial

Free
Philip C. Amrein, MD, Eyal Attar, MD, Tak Takvorian, M.D., Ephraim Hochberg, Karen K. Ballen, MD, Kathleen M. Leahy, Donna Neuberg, ScD, Jennifer R. Brown, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3162.
https://doi.org/10.1182/blood.V112.11.3162.3162
Published: 2008
Journal Articles

Early Interim FDG-PET Scan Predicts Outcome in Non-Bulky Limited Stage Hodgkin Lymphoma, but may Not Guide Use of Consolidative Radiotherapy.

Free
Jeffrey A. Barnes, M.D., Ann S. LaCasce, MD, Christiana E. Toomey, Ephraim Hochberg, Alfred I. Lee, George P. Canellos, MD, Jeremy S. Abramson, MD
Journal: Blood
Blood (2008) 112 (11): 1453.
https://doi.org/10.1182/blood.V112.11.1453.1453
Published: 2008
Journal Articles

High False Positive Rate with the Use of CT and FDG-PET in Post-Remission Surveillance for Hodgkin Lymphoma.

Free
Dan Zuckerman, MD, Ann Lacasce, MD, Eric Jacobsen, MD, Tak Takvorian, MD, Ephraim Hochberg, MD
Journal: Blood
Blood (2007) 110 (11): 2327.
https://doi.org/10.1182/blood.V110.11.2327.2327
Published: 2007
Journal Articles

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Free
Brief Report
Vincent T. Ho, David Zahrieh, Ephraim Hochberg, Eileen Micale, Jesse Levin, Carol Reynolds, Steve Steckel, Corey Cutler, David C. Fisher, Stephanie J. Lee, Edwin P. Alyea, Jerome Ritz, Robert J. Soiffer, Joseph H. Antin
Journal: Blood
Blood (2004) 104 (4): 1224–1226.
https://doi.org/10.1182/blood-2004-01-0028
Published: 2004
Journal Articles

Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma

Free
Roberto Bellucci, Edwin P. Alyea, Edie Weller, Antoinette Chillemi, Ephraim Hochberg, Catherine J. Wu, Christine Canning, Robert Schlossman, Robert J. Soiffer, Kenneth C. Anderson, Jerome Ritz
Journal: Blood
Blood (2002) 99 (12): 4610–4617.
https://doi.org/10.1182/blood.V99.12.4610
Published: 2002